147 related articles for article (PubMed ID: 2898530)
1. Modulation of ANP receptor-mediated cGMP accumulation by atrial natriuretic peptides and vasopressin in A10 vascular smooth muscle cells.
Bellemann P; Neuser D
J Recept Res; 1988; 8(1-4):407-17. PubMed ID: 2898530
[TBL] [Abstract][Full Text] [Related]
2. Effects of ANP, angiotensin, vasopressin, and endothelin on ANP receptors in cultured rat vascular smooth muscle cells.
Schiffrin EL; Turgeon A; Tremblay J; Deslongchamps M
Am J Physiol; 1991 Jan; 260(1 Pt 2):H58-65. PubMed ID: 1847018
[TBL] [Abstract][Full Text] [Related]
3. Atrial natriuretic peptide binding, cross-linking, and stimulation of cyclic GMP accumulation and particulate guanylate cyclase activity in cultured cells.
Leitman DC; Andresen JW; Catalano RM; Waldman SA; Tuan JJ; Murad F
J Biol Chem; 1988 Mar; 263(8):3720-8. PubMed ID: 2894373
[TBL] [Abstract][Full Text] [Related]
4. Vasopressin-mediated inhibition of atrial natriuretic factor-stimulated cGMP accumulation in an established smooth muscle cell line.
Nambi P; Whitman M; Gessner G; Aiyar N; Crooke ST
Proc Natl Acad Sci U S A; 1986 Nov; 83(22):8492-5. PubMed ID: 2430290
[TBL] [Abstract][Full Text] [Related]
5. Receptor binding, cGMP stimulation and receptor desensitization by atrial natriuretic peptides in cultured A10 vascular smooth muscle cells.
Neuser D; Bellemann P
FEBS Lett; 1986 Dec; 209(2):347-51. PubMed ID: 3025021
[TBL] [Abstract][Full Text] [Related]
6. Atrial natriuretic peptide, oxytocin, and vasopressin increase guanosine 3',5'-monophosphate in LLC-PK1 kidney epithelial cells.
Leitman DC; Agnost VL; Catalano RM; Schröder H; Waldman SA; Bennett BM; Tuan JJ; Murad F
Endocrinology; 1988 Apr; 122(4):1478-85. PubMed ID: 2894298
[TBL] [Abstract][Full Text] [Related]
7. Expression of guanylyl cyclase-A/atrial natriuretic peptide receptor blocks the activation of protein kinase C in vascular smooth muscle cells. Role of cGMP and cGMP-dependent protein kinase.
Kumar R; Cartledge WA; Lincoln TM; Pandey KN
Hypertension; 1997 Jan; 29(1 Pt 2):414-21. PubMed ID: 9039136
[TBL] [Abstract][Full Text] [Related]
8. Modulation of ANP-C receptor signaling by arginine-vasopressin in A-10 vascular smooth muscle cells: role of protein kinase C.
Boumati M; Li Y; Anand-Srivastava MB
Arch Biochem Biophys; 2003 Jul; 415(2):193-202. PubMed ID: 12831842
[TBL] [Abstract][Full Text] [Related]
9. Atrial natriuretic peptide-C receptor-induced attenuation of adenylyl cyclase signaling activates phosphatidylinositol turnover in A10 vascular smooth muscle cells.
Mouawad R; Li Y; Anand-Srivastava MB
Mol Pharmacol; 2004 Apr; 65(4):917-24. PubMed ID: 15044621
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of protein kinase C potentiates atrial natriuretic peptide-stimulated cGMP accumulation in vascular smooth-muscle cells.
Kawabe J; Ohsaki Y; Onodera S
Biochim Biophys Acta; 1992 Dec; 1175(1):81-7. PubMed ID: 1362357
[TBL] [Abstract][Full Text] [Related]
11. Phorbol ester and atrial natriuretic peptide receptor response on vascular smooth muscle.
Yasunari K; Kohno M; Murakawa K; Yokokawa K; Horio T; Takeda T
Hypertension; 1992 Apr; 19(4):314-9. PubMed ID: 1348239
[TBL] [Abstract][Full Text] [Related]
12. Atrial natriuretic peptide induces breakdown of phosphatidylinositol phosphates in cultured vascular smooth-muscle cells.
Resink TJ; Scott-Burden T; Baur U; Jones CR; Bühler FR
Eur J Biochem; 1988 Mar; 172(2):499-505. PubMed ID: 2894985
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of natriuretic-peptide-induced growth inhibition of vascular smooth muscle cells.
Hutchinson HG; Trindade PT; Cunanan DB; Wu CF; Pratt RE
Cardiovasc Res; 1997 Jul; 35(1):158-67. PubMed ID: 9302360
[TBL] [Abstract][Full Text] [Related]
14. Possible mechanisms of age-associated reduction of vascular relaxation caused by atrial natriuretic peptide.
Moritoki H; Yoshikawa T; Hisayama T; Takeuchi S
Eur J Pharmacol; 1992 Jan; 210(1):61-8. PubMed ID: 1350988
[TBL] [Abstract][Full Text] [Related]
15. Natriuretic peptide clearance receptor is transcriptionally down-regulated by beta 2-adrenergic stimulation in vascular smooth muscle cells.
Kishimoto I; Yoshimasa T; Suga S; Ogawa Y; Komatsu Y; Nakagawa O; Itoh H; Nakao K
J Biol Chem; 1994 Nov; 269(45):28300-8. PubMed ID: 7961768
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of atrial natriuretic peptide ANP-C receptor is associated with alterations in G-protein expression in A10 smooth muscle cells.
Anand-Srivastava MB
Biochemistry; 2000 May; 39(21):6503-13. PubMed ID: 10828966
[TBL] [Abstract][Full Text] [Related]
17. Vasopressin-dependent inhibition of the C-type natriuretic peptide receptor, NPR-B/GC-B, requires elevated intracellular calcium concentrations.
Abbey SE; Potter LR
J Biol Chem; 2002 Nov; 277(45):42423-30. PubMed ID: 12196532
[TBL] [Abstract][Full Text] [Related]
18. Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells.
Itoh H; Pratt RE; Dzau VJ
J Clin Invest; 1990 Nov; 86(5):1690-7. PubMed ID: 2173726
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of atrial natriuretic peptide-induced cyclic GMP accumulation in the bovine endothelial cells with anti-atrial natriuretic peptide receptor antiserum.
Ishido M; Fujita T; Shimonaka M; Saheki T; Ohuchi S; Kume T; Ishigaki I; Hirose S
J Biol Chem; 1989 Jan; 264(1):641-5. PubMed ID: 2562841
[TBL] [Abstract][Full Text] [Related]
20. Evaluating atrial natriuretic peptide-induced cGMP production by particulate guanylyl cyclase stimulation in vitro and in vivo.
Hamet P; Tremblay J
Methods Enzymol; 1991; 195():447-61. PubMed ID: 1709714
[No Abstract] [Full Text] [Related]
[Next] [New Search]
